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Enhanced virome sequencing using targeted
sequence capture
Todd N. Wylie,1,2,3 Kristine M. Wylie,1,2,3 Brandi N. Herter,1 and Gregory A. Storch1
1The Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA; 2McDonnell Genome
Institute, Washington University School of Medicine, St. Louis, Missouri 63108, USA
Metagenomic shotgun sequencing (MSS) is an important tool for characterizing viral populations. It is culture independent,
requires no a priori knowledge of the viruses in the sample, and may provide useful genomic information. However, MSS
can lack sensitivity and may yield insufficient data for detailed analysis. We have created a targeted sequence capture panel,
ViroCap, designed to enrich nucleic acid from DNA and RNA viruses from 34 families that infect vertebrate hosts. A com-
putational approach condensed ∼1 billion bp of viral reference sequence into <200 million bp of unique, representative
sequence suitable for targeted sequence capture. We compared the effectiveness of detecting viruses in standardMSS versus
MSS following targeted sequence capture. First, we analyzed two sets of samples, one derived from samples submitted to a
diagnostic virology laboratory and one derived from samples collected in a study of fever in children. We detected 14 and 18
viruses in the two sets, comprising 19 genera from 10 families, with dramatic enhancement of genome representation follow-
ing capture enrichment. The median fold-increases in percentage viral reads post-capture were 674 and 296. Median
breadth of coverage increased from 2.1% to 83.2% post-capture in the first set and from 2.0% to 75.6% in the second
set. Next, we analyzed samples containing a set of diverse anellovirus sequences and demonstrated that ViroCap could
be used to detect viral sequences with up to 58% variation from the references used to select capture probes. ViroCap sub-
stantially enhances MSS for a comprehensive set of viruses and has utility for research and clinical applications.
[Supplemental material is available for this article.]
High-throughput, massively parallel nucleotide sequence analysis
has made in-depth studies of the human microbiome feasible.
Thus far, most microbiome studies have focused on bacteria
(Turnbaugh et al. 2009; Arumugam et al. 2011; Gajer et al. 2012;
HumanMicrobiome Project Consortium2012), although some in-
clude fungi (Paulino et al. 2006; Findley et al. 2013; Cleland et al.
2014;Willger et al. 2014) and viruses (Reyes et al. 2010;Minot et al.
2011; Wylie et al. 2012, 2014; De Vlaminck et al. 2013). Viruses
are particularly understudied, in part due to the challenges of as-
sessing their presence in clinical samples. Viruses as a group have
highly variable genomes, with no gene shared among all viruses
that can be surveyed by an amplicon-based sequencing strategy.
Therefore, studies of viruses based on nucleotide sequencing re-
quire a metagenomic approach. Metagenomic shotgun sequenc-
ing (MSS) is a relatively unbiased, culture-independent method
in which nucleic acid extracted from a sample is sequenced.
Sequence reads are classified based on similarity to reference ge-
nomes. This approach allows comprehensive study of the viral
component of themicrobiome (the virome) and has led to the dis-
covery of novel viruses (for review, see Chiu 2013) and the charac-
terization of viruses present in healthy and sick people (Reyes et al.
2010; Minot et al. 2011; Lysholm et al. 2012; Wylie et al. 2012,
2014; Holtz et al. 2014; Oh et al. 2014; Young et al. 2014). When
adequate numbers of sequence reads are generated, viruses can
be characterized with regard to taxonomy and the presence of
genes associated with virulence and resistance to antiviral drugs.
A limitation of MSS as employed to date for virus detection is
that the amount and proportion of viral nucleic acid in samples
from humans may be very low, and in these cases, few viral se-
quences are generated. In our experience using MSS, we have de-
tected fewer than 10 viral sequences per 25 million sequence
reads generated for a virus that was detected in a sample by a mo-
lecular assay (Wylie et al. 2012). In other instances, we have failed
to detect viruses known to be present based on molecular assays
(Wylie et al. 2012). These difficulties may reflect the small genome
size of some viruses and/or low levels of virus in the sample. This
can be a particular problem for studies of the virome of healthy,
asymptomatic individuals (Wylie et al. 2012, 2014), inwhomvirus
levels may be low. In efforts to increase the sequence yield, purifi-
cation or enrichment procedures have been employed, including
low-speed centrifugation and/or filtration to remove bacterial
and host cells, sample treatment with nucleases to digest nucleic
acid not protected within virions (Allander et al. 2001), or concen-
tration of viral particles by high-speed gradient centrifugation (for
review, see Duhaime and Sullivan 2012). Each of these procedures
may bias against detection of some viruses (Breitbart and Rohwer
2005; Young et al. 2014).
An alternative method for enrichment of viral sequences in a
metagenomic sample prior to sequencing is targeted sequence
capture, a well-established approach for targeted enrichment of
specific nucleic acids. Targeted sequence capture has been used
extensively to assess the human exome, as well as specific gene tar-
gets (Lovett et al. 1991; Albert et al. 2007; Hodges et al. 2007; Okou
et al. 2007). Sequence capture has also been applied to the study of
specific viruses (Depledge et al. 2011; Duncavage et al. 2011;
Koehler et al. 2014). Our aimwas to develop a comprehensive viral
targeted sequence capture panel that could be used to (1) assess all
viruses known to infect vertebrate cells and (2) detect divergent
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viruses. To this end, we created ViroCap, a targeted sequence cap-
ture panel that enhances the detection of a comprehensive set of
viruses with vertebrate hosts. Herewe describe the first application
of ViroCap to enrich a broad range of viruses from human clinical
samples.
Results
ViroCap includes targets from34 viral families, comprising 190 an-
notated viral genera and 337 species (Fig. 1). Included viruses rep-
resent all DNA and RNA viruses with sequenced genomes from
vertebrate hosts, except human endogenous retroviruses, which
were excluded due to their prevalence within the human genome.
Nearly 1 billion bp of viral genome sequenceswere condensed into
<200 million bp of targets (Supplemental Table S1) using k-mer
and clustering analyses to define a unique set of reference sequenc-
es, as described in the Methods.
Analysis of clinical and research samples with ViroCap
We evaluated the effectiveness of detecting DNA and RNA viruses
in MSS data compared with ViroCap targeted sequence capture
data in two sets of human samples. In experiment 1, the sample
set consisted of clinical samples that had been found to be positive
by molecular tests in the Diagnostic Virology Laboratory at
St. Louis Children’s Hospital. Nucleic acid extracts available in
the Virology Laboratory were pooled, and a sequencing library
was prepared from this pooled nucleic acid (see Methods). In ex-
periment 2, eight patient samples from a research study of young
children with fever (Colvin et al. 2012; Wylie et al. 2012) were se-
lected for use in the present study because each had been found to
be positive for one or more viruses when tested by batteries of PCR
assays used in that study. Individual sequencing libraries were pre-
pared from each of the eight samples as described in the Methods
and pooled for sequencing. Experiments 1 and 2 were analyzed in
separate sequencing runs. In each experiment, sequencing librar-
ies were divided, and the same library was sequenced without tar-
geted sequence capture (precapture) and following targeted
sequence capture using ViroCap (post-capture).
In experiment 1, we detected 10 viruses in the precaptureMSS
data (Table 1). After targeted sequence capture using the same se-
quencing library, we detected the same 10 viruses plus four addi-
tional viruses. Targeted sequence capture resulted in dramatic
improvements in all sequence coverage metrics (Table 1; Supple-
mental Table S2), including number and percentage of viral reads,
breadth and depth of coverage, and coverage gaps. In experiment
1, the median increase in percentage of viral reads was 674 (range,
>13–9335), and the median breadth of coverage increased
from 2.1% (range, 0%–89.8%) to 83.2% (range, 0.8%–100%).
Illustrative examples are shown in Figure 2A–D.
In experiment 2, 11 viruses were detected in the precapture
MSS data (Table 2). After targeted sequence capture with ViroCap
using the same sequencing libraries, we detected those 11 viruses
plus seven additional viruses. Thus, in the two experiments
Figure 1. Taxonomic distribution of target genomes included in ViroCap. Shown are the viral groups and families included in the ViroCap targeted se-
quence capture panel. A highlighted subset illustrates underlying genera. To view complete genera for all families, see Supplemental Figure S1A.
Taxonomic assignments were obtained from the NCBI Taxonomy Viewer (http://www.ncbi.nlm.nih.gov/genomes/GenomesGroup.cgi?
opt=virus&taxid=10239).
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together, the number of viruses detectedwent from21 to 32, a 52%
increase. All of the viruses detected in both experiments were con-
firmed by PCR assays except for a torque teno virus in the clinical
pool, which was not evaluated by PCR (Table 1; Supplemental
Tables S8, S9). Viruses detected encompassed 19 genera from 10
families (Supplemental Fig. S1). In experiment 2, we again found
that targeted sequence capture resulted in dramatic improvements
in sequencing parameters. In experiment 2, the median fold in-
crease in percentage of viral reads was 296 (range, >56–2722),
and the median breadth of coverage increased from 2.0% (range,
0%–99.9%) to 75.6% (range, 13.5%–100%). Illustrative examples
are shown in Figure 2E–H.
By use of targeted sequence capture, >80% breadth of cover-
age of the viral genomes was obtained for 16 of 32 viruses, includ-
ing diverse DNA and RNA genomes of sizes ranging from 5–161 kb
(Tables 1, 2; Supplemental Tables S2, S3). Greater than 90%
breadth of coverage was obtained for 12 of 32 viruses, and eight vi-
ruses had 100% coverage. Precapture, the median gap size in ge-
nome coverage was 1704 bp (range 4–152,261 bp), and post-
capture, the median gap size was 82 bp (range 0–13,734 bp)
(Supplemental Tables S2, S3). High genome representationwas ob-
tained for multiple viruses in the same capture reaction, as exper-
iments 1 and 2 were each single, independent capture reactions
encompassing multiple samples (see Methods).
Targeted sequence capture identifies divergent viral sequences
To determine whether or not divergent sequences could be identi-
fied using targeted sequence capture, we tested ViroCap on sam-
ples containing anelloviruses, a highly divergent group of ssDNA
viruses that have a common genome structure but may have
up to 30%–50%nucleotide sequence diversity among separate spe-
cies (Ninomiya et al. 2007; de Villiers et al. 2011).We selected anel-
lovirus-positive samples that we had previously characterized
using multistrand displacement amplification followed by high-
throughput sequencing. After assembling the precapture sequenc-
es to generate contiguous sequences (contigs), we identified anel-
lovirus contigs >1 kb in length. The contigs had varying degrees
of similarity to the reference genomes used in the ViroCap panel
based on BLAST alignments, ranging from 58%–98% nucleotide
sequence identity for the top high-scoring segment pair (HSP)
alignment (Fig. 3A; Supplemental Table S4). All of the contigs as-
sembled using the precapture sequence data were also detected
post-capture. The contig with 58% identity to the reference data-
base was missing 13% of its length post-capture (Fig. 3A). The con-
tig with the next lowest percentage identity to the reference
database (62%) was fully sequenced (i.e., 100% breadth-of-cover-
age) (Fig. 3A,B). Figure 3B illustrates the nucleotide sequence
matches/mismatches between the contig and the most similar ref-
erence genome in the sequences used for the ViroCap design.
These results demonstrate that targeted sequence capture using
the ViroCap panel allows us to identify variant virus sequences
having as low as 58% nucleotide sequence identity.
Specificity of targeted sequence capture
In order to determine whether ViroCap systematically enriched
off-target sequences, we compared the filtering and classification
statistics of the nonviral sequences in the precapture MSS and
targeted sequence capture data (Supplemental Table S5;
Supplemental Figs. S2, S3). If our probes were specific, we would
not observe any systematic enrichment of specific human




















P1 34,794 5 8103 1300 0.9 83.6 <0.1 (0.1) 19.3 (52.7)
Human bocavirus 1 P2 5299 110 15,277 111 68.6 100.0 1.8 (2.0) 251.1 (122.1)
Influenza A virus (H3N2) P3 13,267 4 46,540 9335 2.4 74.0 <0.1 (0.3) 263.0 (394.4)
Influenza B virus P4 14,452 0 513 >513f 0 9.8 0 2.6 (0.7)
Human parvovirus B19 P5 5596 1867 474,849 204 89.8 100.0 28.8 (17.9) 7,367.9 (4,193.0)
Norovirus GII-4 P6 7560 72 527,656 5,880 46.5 98.4 0.8 (1.1) 5,870.4 (8,194.3)
Parechovirus 1 P7 7339 0 13 >13f 0 8.0 0 0.2 (0.6)
BK polyomavirus P8 5142 1 1520 1220 1.6 88.6 <0.1 (0.1) 24.9 (32.2)
JC polyomavirus P9 5121 5 2760 443 8.6 98.5 0.1 (0.3) 46.3 (54.0)
Human rhinovirus 15 P10 7134 8 9624 965 8.8 82.9 0.1 (0.3) 115.9 (170.3)
Human respiratory
syncytial virus, type B
P11 15,283 9 67,778 6042 3.0 89.5 <0.1 (0.3) 350.1 (1,667.2)
Human herpesvirus 1 P12 152,261 0 14 >14f 0 0.8 0 <0.1 (0.1)
Torque teno virus P13 3260 1 447 447 1.78 60.74 0.02 (0.13) 10.4 (23.4)
Human herpesvirus 3 P14 125,030 0 834 >834f 0 8.33 0 0.6 (3.5)
Precapture indicates metagenomic shotgun sequencing without targeted sequence capture; post-capture, metagenomic shotgun sequencing using
(ViroCap) targeted sequence capture.
aViruses listed were incorporated into a viral pool that was subjected to MSS without and with targeted sequence capture, as described in the text.
bViral reads per million sequences generated precapture and post-capture are statistically different (P < 0.0001, Wilcoxon test).
cMSS of the virus pool without targeted sequence capture yielded 7,458,192 total reads.
dMSS of the virus pool after targeted sequence capture yielded 9,295,438 total reads.
ePVR (percentage viral reads) fold increase indicates percentage of post-capture viral reads divided by percentage of precapture viral reads.
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chromosomes or bacterial genomes post-capture. However, we an-
ticipated a small amount of variation because the targeted se-
quence capture library had been through more sample handling
in the form of incubations, dilutions, and amplifications. We
found that the proportions of the nonviral sequences were
strongly correlated (Pearson’s correlation value: r = 0.9881–
0.9996) (Supplemental Table S5; Supplemental Fig. S2). A slightly
higher percentage (mean, 5.8%;median, 5%; range, 0%–10.7%) of
reads aligned to nonviral reference genomes in the post-capture
data compared with precapture in all but one of the samples.
However, the distribution of sequences among reference genomes
did not show a systematic bias. This can be seen in the conserved
distribution of sequences among human chromosomes (Supple-
mental Fig. S3).
Discussion
We designed the ViroCap panel to enhance the sensitivity of MSS
for comprehensive detection of known vertebrate viruses, as well
as to detect divergent viruses that have nucleotide sequence simi-
larities to known viruses. Here we have demonstrated that targeted
sequence capture using ViroCap dramatically increases the
amount of viral sequence obtained from human samples com-
pared with conventional MSS, greatly enhancing the resolution
of genomic characterization and increasing the number of viruses
detected by >50%. Enhancement was demonstrated for DNA and
RNA viruses frommultiple diverse families. The increased sensitiv-
ity will be valuable inmultiple research applications, including de-
scriptions of the human virome, and will also improve the
potential forMSS as a diagnostic tool in human and animal health.
The dramatic enrichment of viral nucleic acids present within
the targeted sequence capture libraries offers important advantag-
es. First, as we demonstrate, MSS with ViroCap can be used to gen-
erate complete or nearly complete genome sequences directly from
clinical samples, including thosewith very lowproportions of viral
nucleic acid, without culturing the viruses. Availability of exten-
sive sequence data provides the opportunity to distinguish among
closely related virus subtypes or even among viral strains, which
might not be distinguished by other types of assays. In the data
set presented here, we demonstrated the ability to type rhinovirus-
es and distinguish between human herpesvirus 6B and 6A, adeno-
virus types A and C, and polyomaviruses JC and BK. Notably,
influenza Aviruswas identified precapture but could only be typed
as an H3N2 virus post-capture. Elsewhere, we used ViroCap to se-
quence the enterovirus D68 genome directly from clinical samples
Figure 2. Targeted sequence capture enrichment. Examples are given
showing the impact of targeted sequence capture on breadth and depth
of genome coverage for eight representative viral genomes (A–H). For illus-
trative purposes, all of the coverage panels in this figure have been normal-
ized by removing (deduplicating) reads based on identical alignment start-
sites. Nucleotide positions along the reference genome are shown on the
x-axis. The depth of deduplicated reads is shown on the y-axis. The shaded
portion indicates the sequence coverage (breadth and depth) for each vi-
rus. Post-capture sequence coverage is represented in the larger panels in
blue; precapture sequence coverage is shown in the insets in red. Note that
y-axis ranges are different for each panel. At the top of each panel is shown
the breadth of coverage (BoC) for the sample. The header of each panel
includes breadth of coverage gain (BoC gain), sample id, and reference ge-
nome name and NCBI version number. BoC gain is calculated by subtract-
ing the percentage of the length of the reference genome that was
covered by sequence reads in precapture MSS from the percentage of
the length of the reference genome covered by post-capture sequence
reads.
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(Wylie et al. 2015), and in that work, the extensive sequence data
that we obtained allowed us carry out detailed comparative analy-
sis of closely related strains that differed at a limited number of
nucleotide positions. Second, the use of ViroCap can reduce the
depth of sequencing needed to detect viruses in samples. Because
targeted sequence capture results in a large increase in the per-
centage of sequencing reads that are viral (Tables 1, 2; Fig. 2;
Supplemental Tables S2–S4), ViroCap achieves better viral cover-
age while requiring the generation of fewer total sequence reads.
This increased efficiency has the potential to lower sequencing
costs.
An important feature of ViroCap is the tiling of capture
probes across genomes, including highly conserved regions that
may allow detection of genomic fragments of divergent viruses
that share little overall sequence homology with known viruses.
We illustrated such capability using anelloviruses containing
divergent nucleotide sequence (Fig. 3). In addition, the inclusion
of Genome Neighbor targets enhanced our design not only by ex-
panding beyond the tiled Reference Sequence (RefSeq) viruses but
also by adding sensitivity for genomic regions where RefSeq cap-
ture probes alone might not have captured divergent strains (see
Methods). ViroCap cannot detect viruses that do not share any nu-
cleotide sequence similarity to known viruses; however, we note
that because the enrichment of viral nucleic acids occurs after se-
quence library construction, the uncaptured portion of the library
could subsequently be sequenced for additional attempts at path-
ogen discovery. Furthermore, the ViroCap panel is extensible and
will be updated periodically with new viral sequences as they are
added to RefSeq and the Genome Neighbors databases. Updates
will be publicly available through our GitHub repository (see
Data Access).
There were a few genomes (fewer than 10) in the NCBI refer-
ence databases that had been cloned into bacterial vectors prior to
sequencing, and the deposited viral genome sequences contained
bacterial vector sequence.We were not aware of this prior to probe
design, so ViroCap includes capture probes that target these
sequences. This resulted in enrichment of some sequences (on av-
erage 1.1% of total nonviral reads) that were subsequently recog-
nized by our analysis pipeline as bacterial based on nucleotide
sequence alignment. In subsequent versions of ViroCap, we will
filter out these bacterial vector sequences.
In the experiments reported here, we pooled sequencing li-
braries prior to targeted sequence capture in order to reduce cost,
but we still achieved enhanced detection of multiple viruses of
varying abundance. As has been reported for strategies that involve
sequencing indexed, pooled libraries (Kircher et al. 2012), we ob-
served some sample cross-contamination. This cross-contami-
nation is recognizable when a high number of viral sequences
are detected in the truly positive sample, while few sequences
(<0.05% of the viral sequences in the truly positive sample) of
the same virus are detected in other samples in the pool. In a clin-
ical setting, each sample would optimally be captured and
Figure 3. Targeted sequence capture identifies divergent sequences. (A) The percentage identity of the top high-scoring segment pair (HSP) identified
from the BLAST alignment of anellovirus contig sequences to the references used to design ViroCap is plotted on the y-axis. The x-axis represents the per-
centage of the length of the anellovirus contig covered after targeted sequence capture. (B) This coverage plot represents the sequence coverage of a diver-
gent anellovirus contig sequence. The figure is designed as described in the figure legend for Figure 2, with the following addition: The post-capture
coverage plot is shaded to show regions of nucleotide sequence variation between the anellovirus contig and the most similar reference genome in the
ViroCap panel. Dark shading represents areas of identical sequence, and each position with nucleotide mismatch between aligned sequences is shown
in the lighter color. All of the HSPs are shown, rather than just the top HSP.
Enhanced virome sequencing using sequence capture
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sequenced independently to reduce the possibility of sample cross-
contamination. However, future methodological improvements
could allow pooling of clinical specimens.
The success of viral targeted sequence capture is affected by
the representation of the virus in the sequencing library. In our
sample preparation, total nucleic acid extracted from the sample
was reverse transcribed and randomly amplified prior to library
construction (Wang et al. 2003), allowing detection of DNA and
RNA viral genomes within the same sequencing experiment. The
uneven sequence representation observed for some genomes
(Fig. 2) is likely due in part to detection of messenger RNA, whose
abundance reflects patterns of gene expression, as well as to primer
biases during the reverse transcription and amplification steps.
Capture hybridization may also induce bias, in that sequences
that diverge from target probe sequences may be captured less ef-
ficiently than those with exact or nearly exact matches to the
probe. Taken together, these data suggest that further improve-
ment in the performance of viral targeted sequence capture may
be achievable by improving efficiency of reverse transcription, am-
plification, and library construction, while continuing to update
the ViroCap panel as new, divergent genome sequences become
available.
Methods other than genome sequencing have been used for
virus characterization and discovery, including Virochip, a micro-
array-based method for detection/genotyping of viral pathogens
(Wang et al. 2002; Chen et al. 2011), and PathoChip, a microarray
designed to detect viruses and othermicrobial pathogens (Baldwin
et al. 2014). While designed to detect known viruses by means of
microarray probe spotting, this technology has also shown the
ability to detect emerging viruses (Wang et al. 2003; Yu et al.
2012). The primary difference between the designs of these micro-
arrays and ViroCap targeted sequence capture is that the latter ap-
proach targets complete viral genomes while the microarrays
target smaller, discrete genomic regions. The results obtained
from each approach also differ significantly. The microarray ap-
proach detects the presence of a virus but does not directly provide
sequence information. In contrast, MSS enhanced by ViroCap tar-
geted sequence capture provides sequence data, sometimes cover-
ing the entire genome.
In conclusion, ViroCap greatly enhances the sensitivity of
MSS for nucleotide sequence–based virus detection. To our knowl-
edge, ViroCap represents the first effort to apply a targeted se-
quence capture approach to the detection of a comprehensive
set of viruses. Its research applications are far reaching, allowing
a new, higher-resolution view of eukaryotic DNA and RNA viruses
in the microbiome. ViroCap should also help realize the potential
of MSS as a clinical diagnostic tool that can simultaneously detect
viruses and provide immediate characterization, including taxo-
nomic assignment, strain typing, virulence characteristics, and
anti-viral drug resistance genotyping. ViroCap could also be mod-
ified into a tool for broader pathogen identification, which might
include a comprehensive set of human pathogens: genes from vi-
ruses, bacteria (e.g., toxin genes, antibiotic resistance genes), fungi,
protists, and other microbes.
Methods
Taxonomy selection
At the time, we designed the ViroCap panel, NCBI GenBank had
available for download a total of ∼1 Gb of sequence representing
440 viral families, well beyond the 200Mb of target space support-
ed by the custom SeqCap EZ library format (NimbleGen).
Therefore, we developed the following approach for selecting rep-
resentative targeted sequence capture probes. Because we were in-
terested in studying viral diseases of humans, we excluded
bacteriophages and endogenous human retroviruses. We also spe-
cifically did not include references from the following NCBI viral
reference genome database host categories: algae, archaea, bacte-
ria, diatom, environment, fungi, invertebrates, plants, and proto-
zoa. After filtering, our target list contained reference sequences
from the following host categories: human, vertebrates, and “un-
known.” This list included viruses that could have both vertebrate
and invertebrate hosts, such as vertebrate viruses with insect vec-
tors. Based on these broad viral-host categories, we downloaded
all of the associated viral reference sequences in each chosen cate-
gory fromNCBI (accessed February 3, 2014). These sequences com-
prise the core reference database from which our capture library
is designed. Our capture library includes targets from 34 viral fam-
ilies composed of 190 annotated viral genera and 337 species
(Fig. 1; Supplemental Tables S6, S7). Sources of viral sequences in-
clude complete representation of the viral genomes from NCBI’s
RefSeq collection, complementary representation of unique re-
gions from Genome Neighbor targets, selected representation of
NCBI Influenza Virus Resource sequences, and the entirety of
the probe space represented on the Virochip microarray (Yu et al.
2012), GEO accession number GPL15905. The methods used to
consolidate these database sequences follow.
RefSeq
NCBI’s RefSeq (http://www.ncbi.nlm.nih.gov/refseq/) genome
collection is a database of taxonomically diverse entries represent-
ing comprehensive,well-annotatedgenomesequences (Pruitt et al.
2014; Tatusova et al. 2014). As RefSeq entries are the most com-
plete sequence representatives in terms of annotation andmetada-
ta consistency, we targeted selected viral RefSeqs by tiling of
targeted sequence capture probes across the entire length of each
RefSeq’s genome, with the intention of capturing the entire
viral genome. For our capture library, RefSeq nucleotide FASTA se-
quences were downloaded for desired viral-host categories (human;
vertebrates; vertebrates, human; vertebrates, invertebrates; verte-
brates, invertebrates, human; invertebrates, vertebrates; unknown)
using both the online NCBI taxonomy viewer (http://www.ncbi
.nlm.nih.gov/genomes/GenomesGroup.cgi?opt=virus&taxid=10239),
as well as the RefSeq-specific FTP site (ftp://ftp.ncbi.nlm.nih.gov/
refseq/release/viral). Entries were merged to avoid redundancy.
RefSeq targets were pooled with the other sequence candidates
(see Design Consolidation). A total of 1456 RefSeq FASTA entries
(26.9 Mb) representing 190 viral genera were completely tiled for
inclusion in the ViroCap library, accounting for 13.5% of the total
capture library’s target space.
Genome Neighbors
While RefSeq entries are single, canonical species representations,
other complete or partial viral sequences also exist in DDBJ/EMBL/
GenBank. In the case of viral sequences, there is extensive redun-
dancy in these databases due to the large number of similar viral
strains, isolates, and mutants. Therefore, non-RefSeq (e.g., DDBJ,
EMBL, GenBank) nucleotide sequences of complete viral genomes
that belong to the same species as a RefSeq sequence are classified
as Genome Neighbors for that reference sequence, provided that
they match all of the criteria that were used to select complete ge-
nomic sequences (Bao et al. 2004). At the time of our ViroCap pan-
el design, GenomeNeighbors (sequences downloaded from Entrez
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2014) in total represented an additional 56,314 entries and 507.1
Mb of sequence, more than 2.5 times our SeqCap EZ capture target
sequence space limit. Therefore, an alternative target selection ap-
proach was employed to add diversity to our RefSeq selections by
selecting unique, complementary Genome Neighbor sequences.
RefSeq and Genome Neighbor sequence association
We began the process of variant sequence selection by identifying
conserved regions in Genome Neighbors already represented by
completely tiled RefSeq capture probes. First, we associated our
viral RefSeq selections with corresponding Genome Neighbors.
This was performed by downloading Genome Neighbor annota-
tion files from NCBI (http://www.ncbi.nlm.nih.gov/genomes/
GenomesGroup.cgi?opt=virus&taxid=10239) and associating the
information with our RefSeq annotation files, by means of ad
hoc Perl parsing and coupling scripts (for results, see Supplemental
Tables S6, S7). Once associated, the parent RefSeq sequences could
be compared with related Genome Neighbor sequences to deter-
mine conserved and divergent nucleotide regions. Each viral
RefSeq entry was individually reviewed, along with associated
Genome Neighbor entries. FASTA sequences were collected for
each RefSeq entry and its related Genome Neighbors for subse-
quent k-mer analysis.
K-mer analysis
Each of the Genome Neighbor sequences was split into 100-bp
k-mers by means of an exhaustive 1-bp sliding window algorithm,
as depicted in Supplemental Figure S4. The resultant output thus
included all possible 100-bp sequences based on the combined
Genome Neighbor sequence space. As our SeqCap EZ targeted se-
quence capture probe lengths are 100 bp, the sequences generated
by the sliding window algorithm represent the total number of
possible probe combinations based on the aggregate of Genome
Neighbor sequences. Based on our conservative expectation of hy-
bridization/homology at the capture probe level, we then clustered
all of the Genome Neighbor 100-mers back to the parent RefSeq
sequence at ≥90% sequence identity using length-sorted FASTA
entries and theUCLUST (Edgar 2010) package (version 1.1.579; pa-
rameters: –rev –id 0.90). Given that all of our candidate sequences
were 100 bp in length and all RefSeq entries are >100 bp, UCLUST
always used the longer RefSeq as the first seed (centroid) inwhich to
attempt folding of other sequences. As the parent RefSeq had com-
plete probe tiling in our design, any Genome Neighbor 100-mer
with ≥90% identity was considered already represented in our
capture library and therefore discarded. Genome Neighbor 100-
mers with <90% identity were chosen for inclusion in the cap-
ture library. As the sliding window approach produces 100-mers
that overlapped one another, we merged overlapping 100-mers
based on their Genome Neighbor genomic coordinates into sin-
gle contiguous spans using BEDTools (Quinlan and Hall 2010)
functions.
Genome Neighbor sub-sequences
Resultant subsequences were excised as FASTA entries from
corresponding Genome Neighbor references using WU-BLAST’s
(http://blast.wustl.edu) xdget application and added to the
ViroCap panel. These supplementary entries are easily identifiable
in our final target design, as the FASTA headers for the entries list
the original parent sequence ID with the excised span indicated
in curly braces (e.g., gi|1249624|emb|A28090.1|HPV42 [partial] ge-
nomic sequence {SQ 2444-2644}). In this manner, for each RefSeq
species, we generated Genome Neighbor subsequences from 100
bp to 21 kb in length to add to our capture panel.
These processing steps reduced the aggregate input Genome
Neighbors targeted sequence space from 507.1 Mb to 153.2 Mb
(Supplemental Table S1), and these sequences were pooled with
our other targeted capture sequence targets (see Design Consolida-
tion). A total of 130,808 partial Genome Neighbor FASTA entries
(153.2Mb) were added for capture in our ViroCap library, account-
ing for 77.1% of the total capture library’s target space.
Influenza Virus Resource
We obtained reference sequences from NCBI’s Influenza Virus
Resource database (http://www.ncbi.nlm.nih.gov/genomes/FLU/
FLU.html), which contains sequence data from the NIAID
Influenza Genome Sequencing Project, as well as from GenBank.
At the time of our capture panel design, the NCBI Influenza Virus
Resource contained 305,524 influenza entries, representing 458.1
Mb of sequence. This is 17 times the size of our viral RefSeq selec-
tions and three times the size of our collapsed Genome Neighbor
targets. Our selected RefSeq sequences included 29 influenza
RefSeq entries (each influenza virus segment is represented as a
separate entry), targeted in its entirety. These sequences served as
the core of influenza reference genomes against which all other in-
fluenza sequences were compared. We directly clustered the long
influenza sequences using length-sorted FASTA and the UCLUST
package (version 1.1.579; parameters: –rev –id 0.90). In UCLUST,
a cluster is defined by one sequence, known as the centroid or rep-
resentative sequence. To lessen the computational burden and en-
sure that our core influenza RefSeq genomes were always the
longest first seeds (centroids) in UCLUST’s clustering process, we ar-
tificially concatenated the 29 parent RefSeq sequences into one
linear sequence representation and then split this representation
into six segments ranging in size from18–26 kb. UCLUST preferen-
tially seeded with the long RefSeq construct segments when clus-
tering, ensuring that clustering was first attempted within the
longer, canonical references. ULCUST was run with a requirement
of ≥90% sequence identity to fold into a parent influenza RefSeq
entries segment. Therefore, only sequences that (1) had <90%
identity to influenza RefSeq entries and (2) were subsequent cen-
troids in non-RefSeq clusters were chosen for inclusion in our cap-
ture panel. This process reduced the aggregate input Influenza
Resource Database reference sequence from 458.1 Mb to 15.7 Mb
(Supplemental Table S1). Finally, supplementary influenza targets
were pooled with the other sequence candidates (see Design Con-
solidation). A total of 9759 influenza FASTA entries (15.7Mb) were
added for targeted sequence capture in our ViroCap library, ac-
counting for 7.9% of the total capture library’s target space.
Virochip microarray
Considering the biologically important short sequence signatures
represented on the Virochip panel (Yu et al. 2012), as well as the
comparatively small footprint, we subsumed these sequences
within our targeted sequence capture panel design. The probe se-
quences for the microarray are publicly available at NCBI’s Gene
Expression Omnibus (GEO) repository (Edgar et al. 2002). We
downloaded this information for Platform GPL15905 (Viro5AG-
60k) as a text file (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GPL15905). This platform included more than 60,000
oligonucleotides of length 60–70 bp, corresponding to 3.1 Mb of
probes (Supplemental Table S1). Virochip targets were pooled
with the other sequence candidates (see Design Consolidation).
Upon review, 1.3 Mb of the probes were already directly repre-
sented by RefSeq, Genome Neighbor, and Influenza Viral
Resource sequences during capture library design and synthesis.
Therefore, the remaining 25,749 (60–70 bp) Virochip FASTA
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entries of 1.8-Mb total size were added to ViroCap, accounting for
<1% of the total targeted sequence capture panel.
Design consolidation
All of our selected candidate target sequences from RefSeq,
Genome Neighbors, Influenza Virus Resource, and the Virochip
microarray were combined into a single FASTA sequence file.
Human endogenous retroviruses were removed from inclusion
by means of a two-part process: (1) Entries were filtered by taxo-
nomic annotation indicating human endogenous retrovirus iden-
tity, and (2) the remaining entries were BLAST-aligned to the
GRCh37-lite build of the human reference genome to remove se-
quenceswith high percentage identity (≥75%) at the 100-bp probe
level. Finally, sequences were hard-masked (i.e., bases converted to
N’s) in low complexity regions using the DUST (R Tatusov and DJ
Lipman, unpubl.) software module. The final ViroCap targeted se-
quence capture panel consists of 185,835 FASTA sequences total-
ing 198.9 Mb (see Taxonomy Selection).
NimbleGen sequence capture design
Our consolidated target sequences were submitted to Roche
NimbleGen onMarch 31, 2014 for capture library design and syn-
thesis. As our final ViroCap design required 198.9Mb,manufactur-
ing was implemented under the custom NimbleGen SeqCap EZ
Developer Library format, which has a maximum capture space
of 200 Mb of nonhuman sequence. NimbleGen’s Sequence
Capture design offered up to 2.1 million of 50–105mer sequence
probes. It was at the discretion ofNimbleGen, based on proprietary
algorithms, to redistribute probes for better capture uniformity, re-
dundancy, and comprehensive target base coverage. NimbleGen
provided us with a proposed capture design accompanied by coor-
dinate (GFF, BED) files and associated sequence coverage metrics
on April 14, 2014. The design set contained probe representation
generated by first masking all but one exact copy of each 100-
mer in our original FASTA file, tiling the unmasked regions, screen-
ing the resulting probes against the (hg19) human genome, and fi-
nally selecting only those probes that had no matches in the
human genome as determined by the SSAHA (Ning et al. 2001) al-
gorithm. NimbleGen provides two metrics for assessing in silico
targeted sequence capture design coverage: (1) Target bases cov-
ered with 0-bp-offset are determined by counting target bases
directly represented in probe sequences, and (2) target bases cov-
eredwith 100-bp-offset are determined by counting all target bases
within 100 bp of a probe. The capture design provided 95.9%0-bp-
offset coverage and 99.6% 100-bp-offset coverage of our initial
198.9-Mb target request. We approved the design on April 17,
2014 for capture library synthesis and received our first
12 SeqCap EZ Library reactions for in-house Illumina sequencing
and analysis on April 28, 2014.
Human subjects approval and sample selection
Samples were collected under protocols approved by the Human
Research Protection Office at Washington University School of
Medicine (IRB protocol nos. 201106177, 201102561, and
201102045). Samples were selected to represent a broad range of
viruses that are commonly encountered in the clinical laboratory
and in our research studies. Viruses were identified in samples
based on clinical laboratory test results in the Diagnostic
Virology Laboratory at St. Louis Children’s Hospital or by PCR as-
says and sequencing results carried out in previous studies (Colvin
et al. 2012; McElvania TeKippe et al. 2012; Wylie et al. 2012).
Specimens of nasopharyngeal secretions, plasma, and stool were
included.
Sequencing
Total nucleic acid was extracted from clinical samples using the
EasyMag NucliSENS instrument (bioMerieux). Samples were pro-
cessed in one of twoways. In experiment 1, nucleic acids from clin-
ical specimens from the Diagnostic Virology Laboratory were
combined, and the resulting pooled nucleic acid was used as input
for a single sequencing library (constructed as described below).
These samples are designated with a sample identification prefix
of “P” in the various tables and figures. Alternatively, in experi-
ment 2, individual sequencing libraries were made from each set
of eight different specimens prior to combining the libraries for se-
quencing. These samples are designated with a sample identifica-
tion prefix of “S” in the various tables.
For sequencing libraries, DNA and RNA viruses were assessed
in the same assay as previously described (Wang et al. 2003).
Specifically, the RNA in the total nucleic acid was reverse tran-
scribed with reverse transcriptase (Promega) and random nonom-
ers tagged with a conserved sequence (5′-GTTTCCCAGTCACGA
TA-3′) to be used for subsequent amplification (Integrated DNA
Technologies), and second strand synthesis was carried out with
Sequenase V2.0 DNA polymerase (Affymetrix). DNA and RNA
were subsequently amplified with Accuprime Taq (Life Technolo-
gies) using the conserved sequence on the ends of the random
primers, and the DNA/cDNA mixture was sheared using the
Qsonica Q800R instrument (Qsonica) to generate fragments
with an average length of 500 bp. Dual-indexed sequencing librar-
ies were constructed using the KAPA low throughput library con-
struction kit (KAPA Biosystems).
For the anellovirus samples, DNA was amplified with the
Illustra GenomiPhi V2 DNA amplification kit (GE Healthcare Life
Sciences); RNA was not assessed. DNA was sheared, and libraries
were constructed fromeach sample as described above. Sequencing
libraries were pooled.
In each case, the libraries were divided, and part was directly
sequenced (precapture) and part was subjected to targeted se-
quence capture with the custom ViroCap probes prior to sequenc-
ing (post-capture). Targeted sequence capture was carried out
according to the manufacturer’s specifications. We carried out
10, 10, and 16 cycles of post-capture linker—mediated PCR for ex-
periments 1 (pooled clinical samples), 2 (individual samples from
the research study), and 3 (anellovirus samples), respectively, prior
to sequencing. The number of cycles was empirically determined
to be the minimum number needed to obtain a 5 nM dilution of
library material for qPCR and loading. Libraries were sequenced
on the Illumina HiSeq 2000 or HiSeq 2500 instrument, generating
100-bp paired-end reads.
Sequence analysis
Viral sequences were identified based on nucleotide and translated
protein sequence alignment against reference genomes. The pipe-
line is adapted from previously described methods (Wylie et al.
2014), except that nucleotide alignments were carried out using
BWA-MEM with default settings (Li and Durbin 2009). Because
many similar genomes are included in the reference database, we
used the initial alignment statistics for each sample to choose a sin-
gle reference from each species to calculate and report coverage
statistics. References were chosen based on having the highest
number of reference bases covered. Sequences were realigned to
the selected references with BWA-MEM for calculation of coverage
statistics and comparison of samples precapture and post-capture.
Sequence alignments were evaluated with SAMtools (Li 2011), and
sequence coverage was determined with RefCov (http://gmt.
genome.wustl.edu/packages/refcov/) and visualized with Plot2
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coverage panels in Figures 2 and 3 were normalized by removing
(deduplicating) reads based on identical alignment start sites using
the SAMtools rmdup command. For each alignment start site, only
the highest-quality readwas retained for forward and reverse align-
ment orientations. Therefore, for the 100-bp read data shown in
each coverage panel, the theoretical maximum depth is 200×.
Anellovirus contigs were assembled from the precapture
sequence data using IDBA-UD (Peng et al. 2012). Contigs were
aligned against the sequence database used to design the
ViroCap panel using BLAST (Altschul et al. 1997) with the
following parameters to detect low-similarity sequences: -G 5 -E
2 -r 1 -q -1. The percentage identity of the top HSP is reported in
Supplemental Table S3.
Data access
Data files associated with our ViroCap panel are publicly available
through the https://github.com/WashU-PMG/ViroCapGitHub re-
pository. Hosted files include 198.9Mb of ViroCap target sequence
in FASTA format, taxonomy information, corresponding RefSeq
and Genome Neighbor associations, and NimbleGen’s target de-
sign coverage metrics for 0- and 100-bp-offset intervals. MSS data
used for ViroCap evaluation have been submitted to (with poten-
tially identifiable human sequences removed) the NCBI BioProject
database (http://www.ncbi.nlm.nih.gov/bioproject) under acces-
sion number PRJNA273884.
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